News Awards and Presentations

News:

December 2010: "Summa Researchers Explore Apatone’s Potential to Fight Cancer and Other Diseases." Summa Magazine.

Spring of 2012: "Innovative Anticancer Drugs and Strategies." 2nd International Symposium (IADS-2). Akron, Ohio. 

James Jamison: Co-Organizer of The Innovative Anticancer Drugs and Strategies 1st International Symposium (IADS-1). June 2-4, 2010. Newcastle, England.

Awards:

Apatone Development Center awarded one of the Initial Collaborative Research & Development Grants from The Austen BioInnovation Institute in Akron, 2010

J.M. Jamison, Summa Health System; Y.H. Yun, The University of Akron; V.E. von Gruenigen, Summa Health System; and C-c. Tsai, Kent State University. “Development of Delivery Mechanisms for Liquid Crystalline Pharmaceuticals Using Electrospinning.” 

Presentations

Karen McGuire

“Nucleolar changes and fibrillarin redistribution following Apatone® treatment of human bladder and prostate carcinoma cells.” Innovative Anticancer Drugs and Strategies 1st International Symposium (IADS-1). June 2-4, 2010. Newcastle, England.

“Elucidating the Pathway of Apatone® Induced DNase II Reactivation During Autoschizic Cell Death.” MSA Meeting. July 29, 2009. Richmond, VA. MSA Presidential Award.

Debbie Neal

“Apatone® Exhibits Antitumor Activity Against Prostate Cancer.” Innovative Anticancer Drugs and Strategies 1st International Symposium (IADS-1). June 2-4, 2010. Newcastle, England.

“Apatone® Treatment Inhibits the Inflammatory Response in Human Synovial Fibroblasts Following Metal Particulate Exposure by Reducing NF-kB Levels.” MSA Meeting. July 29, 2009. Richmond, VA.